SCHEMBL565437

SCHEMBL565437

CCC(=O)C=Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
HAO1 Q9UJM8 1/20 0.63
GLA P06280 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
NPC1 O15118 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
MAPT P10636 4/20 0.59
HDAC3 O15379 3/20 0.59
LMNA P02545 3/20 0.59
HDAC4 P56524 2/20 0.59
HDAC1 Q13547 2/20 0.59
HDAC2 Q92769 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
PLIN1 O60240 2/20 0.59
RECQL P46063 2/20 0.59
PLIN5 Q00G26 2/20 0.59
ABHD5 Q8WTS1 2/20 0.59
TNKS O95271 1/20 0.59
HCAR2 Q8TDS4 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565436 1.00 ALDH1A1 (0.63) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL18406217 1.00 ALDH1A1 (0.63) ALDH1A1HAO1GLATDP1NPC1
Hydrochloric Acid SCHEMBL27720367 0.98 ALDH1A1 (0.61) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL23573616 0.90 MAPT (0.70) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL13211526 0.89 HDAC2 (0.59) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL3439644 0.85 HAO1 (0.84) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL316674 0.85 HAO1 (0.84) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL574953 0.84 ALDH1A1 (0.70) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL574952 0.84 ALDH1A1 (0.70) ALDH1A1HAO1GLATDP1NPC1
SCHEMBL12313638 0.83 ALDH1A1 (0.69) ALDH1A1HAO1GLATDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847318-A1 PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES Marrone Bio Innovations, Inc. (US) 2015-03-18 EP claimed
US-20150031534-A1 PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES PRO FARM GROUP, INC. 2015-01-29 US claimed
WO-2013138398-A1 PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES MARRONE BIO INNOVATIONS, INC. (US) 2013-09-19 WO claimed
US-8318085-B2 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. (US) 2012-11-27 US claimed
US-20120035086-A1 Methods and Compositions for Inhibiting Metal Corrosion HALLIBURTON ENERGY SERVICES, INC. (US) 2012-02-09 US claimed
US-8062586-B2 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. (US) 2011-11-22 US claimed
US-20100087340-A1 Methods and Compositions for Inhibiting Metal Corrosion HALLIBURTON ENERGY SERVICES, INC. 2010-04-08 US claimed
EP-1689911-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION Halliburton Energy Services, Inc. (US) 2006-08-16 EP claimed
WO-2005054544-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION HALLIBURTON ENERGY SERVICES, INC. (US) 2005-06-16 WO claimed
US-20050123437-A1 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. 2005-06-09 US claimed
CN-1028098-C Preparation of amino ketone compound MONSANTO CO (US) 1995-04-05 CN claimed
US-4643805-A CONTAINING UNSATURATED OXO PYRIDINE, AROMATIC, FURAN, OR THIOPHENE COMPOUND POPESCU FRANCINE (FR) 1987-02-17 US claimed
JP-61293366-A None JP disclosed
JP-61293367-A None JP disclosed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 US disclosed
US-12304907-B2 Compounds and methods of use TANGO THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
JP-S61293366-A MUSHROOM FLAVOR COMPOSITION T HASEGAWA CO LTD 1986-12-24 JP disclosed
JP-S61293367-A PRODUCTION OF MUSHROOM-LIKE FLAVOR T HASEGAWA CO LTD 1986-12-24 JP disclosed
EP-0043141-B1 PHARMACEUTICAL COMPOSITIONS HAVING ANTIVIRAL ACTIVITY FOR TOPICAL ADMINISTRATION AND THE USE OF 1-(SUBSTITUTED PHENYL)-5-(4-MORPHOLINYL)-1-PENTEN-3-ONE COMPOUNDS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING AN ANTIVIRAL EFFECT MERRELL DOW PHARMACEUTICALS INC. (US) 1984-09-12 EP disclosed
US-4012232-A Stabilized photochromic materials Chu, Nori Y. C. (US) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031534-A1 PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES BLVRB, PRDX6, ACHE ALDH1A1 3340/4885HAO1 2308/4885GLA 1620/4885
US-12304907-B2 Compounds and methods of use F12, C1R, ABCG2 ALDH1A1 128/4885HAO1 2776/4885GLA 1199/4885
US-20260078117-A1 COMPOUNDS AND METHODS OF USE NR3C2, ADRA1A, CNR1 ALDH1A1 100/4885HAO1 321/4885GLA 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.